Eli Lilly India launches obesity awareness campaign
Initiative positions obesity as a chronic disease and highlights role of doctors in evidence-based care
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating tablets
Company secures final approval for ANDA across four strengths; cumulative USFDA ANDA approvals reach 235
MSD appoints Brecht Vanneste as MD for India
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based in Mumbai
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
B&R India hosts Innovations Day 2026 to showcase smart manufacturing solutions
Event highlights intelligent automation, industry collaboration, and next-generation motion control technologies
Biocon receives US FDA approval for Liraglutide Injection gSaxenda
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the United States
Lupin receives US FDA approval for Brivaracetam Oral Solution 10 mg/mL
Company initiates US launch following ANDA approval for bioequivalent to Briviact
Kiran Mazumdar-Shaw awarded Honorary Fellowship of the UK Academy of Medical Sciences
Biocon Group Chairperson recognised for contributions to biomedical science and access to medicines
DGFT rationalises RoDTEP scheme, reduces benefits by 50 per cent
Value caps under the scheme have also been reduced by 50 per cent wherever applicable
FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market: GlobalData
GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 August 2026 PDUFA date, could introduce the first…